New Zealand Health Terminology Service (NZHTS) Implementation Guide
0.1.0 - ci-build
New Zealand Health Terminology Service (NZHTS) Implementation Guide, published by Health New Zealand | Te Whatu Ora. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/daniel-thomson/nzhts/ and changes regularly. See the Directory of published versions
Official URL: https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-urethra-primary-histology | Version: 0.1.0 | |||
Active as of 2024-11-11 | Computable Name: canshare-who-urethra-primary-histology | |||
Other Identifiers: http://canshare.co.nz/fhir/NamingSystem/valuesets#canshare-who-urethra-primary-histology |
Histologies used for urethra primaries, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 3. Tumours of the urinary tract, 9. Neuroendocrine neoplasms, 10. Mesenchymal tumours, 12. Melanocytic lesions or an 'Other' value.
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
Generated Narrative: ValueSet canshare-who-urethra-primary-histology
version: 1; Last updated: 2024-11-05 17:12:33+1300; Language: en-x-sctlang-23162100-0210105
http://snomed.info/sct
where constraint = ^300351000210101 |New Zealand World Health Organization classification of tumors 5th edition urinary and male genital urinary tract histology reference set| OR ^300411000210108 |New Zealand World Health Organization classification of tumors 5th edition urinary and male genital neuroendocrine histology reference set| OR ^300421000210103 |New Zealand World Health Organization classification of tumors 5th edition urinary and male genital mesenchymal histology reference set| OR ^300441000210109 |New Zealand World Health Organization classification of tumors 5th edition urinary and male genital melanocytic lesion histology reference set| OR 74964007 |Other|
Generated Narrative: ValueSet canshare-who-urethra-primary-histology
version: 1; Last updated: 2024-11-05 17:12:33+1300; Language: en-x-sctlang-23162100-0210105
Expansion based on SNOMED CT 21000210109 edition 01-Oct 2024
This value set contains 100 concepts
Code | System | Display - English (English, en) |
51642000 | http://snomed.info/sct | Adenocarcinoma in situ |
25190001 | http://snomed.info/sct | Adenocarcinoma, intestinal type |
63449009 | http://snomed.info/sct | Alveolar rhabdomyosarcoma |
1293127005 | http://snomed.info/sct | Anastomosing haemangioma |
19929002 | http://snomed.info/sct | Angiomyolipoma |
863926008 | http://snomed.info/sct | Angiosarcoma |
1340048006 | http://snomed.info/sct | Benign glomus tumour |
253053003 | http://snomed.info/sct | Benign haemangioma |
301401000210100 | http://snomed.info/sct | Benign sclerosing perivascular epithelioid tumour |
301281000210108 | http://snomed.info/sct | Benign solitary fibrosis tumour |
1156654007 | http://snomed.info/sct | Benign tubular adenoma |
300741000210100 | http://snomed.info/sct | Benign urothelial papilloma |
83343001 | http://snomed.info/sct | Capillary haemangioma |
33377007 | http://snomed.info/sct | Cavernous haemangioma |
1293012008 | http://snomed.info/sct | Cellular angiofibroma |
295171000210106 | http://snomed.info/sct | Clear cell malignant epithelial neoplasm |
1231399003 | http://snomed.info/sct | Clear cell urothelial carcinoma |
448546006 | http://snomed.info/sct | Combined large cell neuroendocrine carcinoma |
1157181004 | http://snomed.info/sct | Dedifferentiated solitary fibrous tumour |
301431000210105 | http://snomed.info/sct | Deep leimyosarcoma |
128735004 | http://snomed.info/sct | Desmoplastic small round cell tumour |
14269005 | http://snomed.info/sct | Embryonal rhabdomyosarcoma |
30289006 | http://snomed.info/sct | Endometrioid carcinoma |
301371000210102 | http://snomed.info/sct | Epithelioid angiosarcoma |
33929001 | http://snomed.info/sct | Epithelioid haemangioma |
51747000 | http://snomed.info/sct | Extra-adrenal paraganglioma |
301331000210104 | http://snomed.info/sct | Extrarenal rhabdoid tumour |
300861000210107 | http://snomed.info/sct | Giant cell urothelial carcinoma |
7429002 | http://snomed.info/sct | Glomangioma |
703603008 | http://snomed.info/sct | Glomangiomatosis |
34550005 | http://snomed.info/sct | Glomangiomyoma |
1293211005 | http://snomed.info/sct | Glomus tumour of uncertain malignant potential |
128908003 | http://snomed.info/sct | Glomus tumour, malignant |
300771000210105 | http://snomed.info/sct | High grade non-invasive papillary urothelial neoplasia with inverted growth pattern |
1290860006 | http://snomed.info/sct | Inflammatory myofibroblastic tumour |
300791000210109 | http://snomed.info/sct | Invasive urothelial carcinoma |
300801000210108 | http://snomed.info/sct | Invasive urothelial carcinoma with trophoblastic differentiation |
300751000210102 | http://snomed.info/sct | Inverted papillary urothelial neoplasm of low malignant potential |
733845009 | http://snomed.info/sct | Inverted urothelial papilloma |
128628002 | http://snomed.info/sct | Large cell neuroendocrine carcinoma |
300821000210100 | http://snomed.info/sct | Large nested urothelial carcinoma |
1162890002 | http://snomed.info/sct | Leiomyoma |
1163022006 | http://snomed.info/sct | Leiomyosarcoma |
300871000210101 | http://snomed.info/sct | Lipid-rich urothelial carcinoma |
301291000210105 | http://snomed.info/sct | Lipomatous solitary fibrous tumour |
300761000210104 | http://snomed.info/sct | Low grade non-invasive papillary urothelial neoplasia with inverted growth pattern |
300841000210106 | http://snomed.info/sct | Lymphoepithelioma-like urothelial carcinoma |
1186968006 | http://snomed.info/sct | Malignant adenomatous neoplasm |
300961000210102 | http://snomed.info/sct | Malignant adenomatous neoplasm of Cowper gland |
300941000210103 | http://snomed.info/sct | Malignant adenomatous neoplasm of Littré gland |
300951000210100 | http://snomed.info/sct | Malignant adenomatous neoplasm of Skene gland |
1292991006 | http://snomed.info/sct | Malignant solitary fibrous tumour |
128639004 | http://snomed.info/sct | Micropapillary urothelial carcinoma |
38958001 | http://snomed.info/sct | Mixed cell adenocarcinoma |
785766008 | http://snomed.info/sct | Mixed neuroendocrine-non neuroendocrine neoplasm |
301311000210106 | http://snomed.info/sct | Monophasic synovial sarcoma |
72495009 | http://snomed.info/sct | Mucinous adenocarcinoma |
300931000210106 | http://snomed.info/sct | Mucinous cystic tumour of urachus |
301341000210107 | http://snomed.info/sct | Mucosal melanoma |
128738002 | http://snomed.info/sct | Myofibroblastoma |
788741008 | http://snomed.info/sct | Myointimoma |
400065005 | http://snomed.info/sct | Myopericytoma |
733844008 | http://snomed.info/sct | Neuroendocrine type combined small cell carcinoma |
2142002 | http://snomed.info/sct | Nodular melanoma |
1078227006 | http://snomed.info/sct | Non-invasive papillary urothelial carcinoma, high-grade |
870763009 | http://snomed.info/sct | Non-invasive papillary urothelial carcinoma, low-grade |
74964007 | http://snomed.info/sct | Other |
128625004 | http://snomed.info/sct | Papillary transitional cell neoplasm of low malignant potential |
703604002 | http://snomed.info/sct | Perivascular epithelioid tumour, benign |
703605001 | http://snomed.info/sct | Perivascular epithelioid tumour, malignant |
300851000210109 | http://snomed.info/sct | Plasmacytoid urothelial carcinoma |
21396005 | http://snomed.info/sct | Pleomorphic lipoma |
1290730007 | http://snomed.info/sct | Poorly differentiated synovial sarcoma |
300881000210104 | http://snomed.info/sct | Poorly differentiated urothelial carcinoma |
300891000210102 | http://snomed.info/sct | Pure squamous carcinoma of urothelial tract |
1208484008 | http://snomed.info/sct | Sarcomatoid urothelial carcinoma |
300901000210101 | http://snomed.info/sct | Singet ring cell malignant adenomatous neoplasm |
74364000 | http://snomed.info/sct | Small cell neuroendocrine carcinoma |
300811000210105 | http://snomed.info/sct | Small nested urothelial carcinoma |
299591000210102 | http://snomed.info/sct | Smooth muscle tumour of uncertain behaviour |
128736003 | http://snomed.info/sct | Solitary fibrous tumour |
301441000210102 | http://snomed.info/sct | Spindle cell and/or sclerosing rhabdomyosarcoma |
27313007 | http://snomed.info/sct | Spindle cell lipoma |
1162767002 | http://snomed.info/sct | Squamous cell carcinoma |
63451008 | http://snomed.info/sct | Squamous cell papilloma |
301421000210108 | http://snomed.info/sct | Superficial leimyosarcoma |
63211008 | http://snomed.info/sct | Synovial sarcoma |
18588008 | http://snomed.info/sct | Synovial sarcoma, biphasic |
53530009 | http://snomed.info/sct | Transitional cell carcinoma in situ |
399564007 | http://snomed.info/sct | Transitional cell carcinoma with glandular differentiation |
399464005 | http://snomed.info/sct | Transitional cell carcinoma with squamous differentiation |
300831000210103 | http://snomed.info/sct | Tubular urothelial carcinoma |
61722000 | http://snomed.info/sct | Tubulovillous adenoma |
300911000210104 | http://snomed.info/sct | Urachal malignant adenomatous neoplasm |
300921000210109 | http://snomed.info/sct | Urachal remnant |
89906000 | http://snomed.info/sct | Verrucous carcinoma |
128859003 | http://snomed.info/sct | Villous adenoma |
1286768001 | http://snomed.info/sct | Well-differentiated neuroendocrine tumour |
1286769009 | http://snomed.info/sct | Well-differentiated neuroendocrine tumour grade 1 |
1286770005 | http://snomed.info/sct | Well-differentiated neuroendocrine tumour grade 2 |
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |